Summary
- Current Price
- As of today, ALLO price is $1.80, up +11.11% on
- Current Price All-Time High
- ALLO price is currently -96.73% below its historical high of $55.00 set on
- Market Cap
- ALLO current market cap is $405M, up +35.19% over the past 365 days
- PE Ratio
- ALLO PE ratio is unknown
- Revenue
- ALLO current annual revenue is $22.00K, down -76.84% year-over-year
- Next Earnings
- The next earnings release for ALLO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Allogene Therapeutics, Inc. |
| Ticker | NASDAQ: ALLO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | allogene.com |
| Employees | 226 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.80 | ||
| Price, 1D Change | +11.11% | |
| $405M | ||
| - | ||
| - | ||
| 1.28 | ||
| $22K | ||
| Revenue, 1Y Change | -76.84% | |
| -$1.32 | ||
| EPS, 1Y Change | +36.60% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.32 | ||
| EPS Estimate | -$0.91 | |
| EPS Est. Change | +31.30% | |
| $22.00K | ||
| Revenue Estimate | $1,670.00 | |
| Revenue Est. Change | -92.41% | |
| $1.80 | ||
| Price Target | - | $7.50 |
| Price Tgt. Change | - | +316.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.01 | -$2.09 | -3.75% | |
| -$1.32 | -$1.32 | +0.20% | |
| -$0.91 | N/A | +31.30% | |
| -$0.89 | N/A | +33.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $130.00K | $95.00K | -26.92% | |
| $34.29K | $22.00K | -35.84% | |
| $1,670.00 | N/A | -92.41% | |
| $15.00K | N/A | -31.82% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +27.66% | ||
| -74.72% | ||
| +35.19% | ||
| -60.67% | ||
| -76.84% | ||
| -99.98% | ||
| +36.60% | ||
| +1.36% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.80 | ||
| $1.31 | ||
| SMA 200 vs Price | -27.05% | |
| $1.55 | ||
| SMA 50 vs Price | -13.89% | |
| 1.28 | ||
| $0.15 | ||
| 58.47 | ||
| 91.32% | ||
| 91.49% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $22.00K | ||
| -$1.32 | ||
| -$13.62M | ||
| -61.90% | ||
| -$257.48M | ||
| -1.17% | ||
| -$257.59M | ||
| -1.17% | ||
| -$243.84M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.22 | ||
| 8.54 | ||
| 8.54 | ||
| - | ||
| - | ||
| -3.69 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.28 | ||
| -1.12 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $422.18M | ||
| $75.22M | ||
| $548.71M | ||
| $303.39M | ||
| $126.53M | ||
| $35.52M | ||
| $90.76M | ||
| $7.51M | ||
| $5.39M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $257.61M | ||
| $243.87M | ||
| $13.64M | ||
| $0.00 | ||
| $13.64M | ||
| $0.00 | ||
| $443.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$200.30M | ||
| $75.69M | ||
| $116.68M | ||
| $694.00K | ||
| -$200.99M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citizens | → | |
| UBS | ||
| JP Morgan | → | |
| JP Morgan | → | |
| JMP Securities | → | |
| Oppenheimer | → | |
| Citigroup | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with ALLO
FAQ
What is the ticker symbol for Allogene Therapeutics, Inc.?
The ticker symbol for Allogene Therapeutics, Inc. is NASDAQ:ALLO
Does Allogene Therapeutics, Inc. pay dividends?
No, Allogene Therapeutics, Inc. does not pay dividends
What sector is Allogene Therapeutics, Inc. in?
Allogene Therapeutics, Inc. is in the Healthcare sector
What industry is Allogene Therapeutics, Inc. in?
Allogene Therapeutics, Inc. is in the Biotechnology industry
What country is Allogene Therapeutics, Inc. based in?
Allogene Therapeutics, Inc. is headquartered in United States
When did Allogene Therapeutics, Inc. go public?
Allogene Therapeutics, Inc. initial public offering (IPO) was on October 11, 2018
Is Allogene Therapeutics, Inc. in the S&P 500?
No, Allogene Therapeutics, Inc. is not included in the S&P 500 index
Is Allogene Therapeutics, Inc. in the NASDAQ 100?
No, Allogene Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Allogene Therapeutics, Inc. in the Dow Jones?
No, Allogene Therapeutics, Inc. is not included in the Dow Jones index
When was Allogene Therapeutics, Inc. last earnings report?
Allogene Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Allogene Therapeutics, Inc. report earnings?
The next expected earnings date for Allogene Therapeutics, Inc. is March 19, 2026
Data Sources & References
- ALLO Official Website allogene.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1737287/000162828025050230/0001628280-25-050230-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1737287/000173728725000036/0001737287-25-000036-index.htm
- ALLO Profile on Yahoo Finance finance.yahoo.com/quote/ALLO
- ALLO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/allo